Automated Quantification of Brain Lesion Volume From Post-trauma MR Diffusion-Weighted Images.

MRI brain mean diffusion (MD) segmentation (image processing) traumatic brain injury

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2021
Historique:
received: 13 07 2021
accepted: 29 12 2021
entrez: 14 3 2022
pubmed: 15 3 2022
medline: 15 3 2022
Statut: epublish

Résumé

Determining the volume of brain lesions after trauma is challenging. Manual delineation is observer-dependent and time-consuming and cannot therefore be used in routine practice. The study aimed to evaluate the feasibility of an automated atlas-based quantification procedure (AQP) based on the detection of abnormal mean diffusivity (MD) values computed from diffusion-weighted MR images. The performance of AQP was measured against manual delineation consensus by independent raters in two series of experiments based on: (i) realistic trauma phantoms ( In realistic TBI phantoms, no statistical differences in Dice similarity coefficient, precision and brain lesion volumes were found between AQP, the rater consensus and the ground truth lesion delineations. Similar findings were obtained when comparing AQP and manual annotations for TBI patients. The intra-class correlation coefficient between AQP and manual delineation was 0.70 in realistic phantoms and 0.92 in TBI patients. The volume of brain lesions detected in TBI patients was 59 ml (19-84 ml) (median; 25-75th centiles). Our results support the feasibility of using an automated quantification procedure to determine, with similar accuracy to manual delineation, the volume of low and high MD brain lesions after trauma, and thus allow the determination of the type and volume of edematous brain lesions. This approach had comparable performance with manual delineation by a panel of experts. It will be tested in a large cohort of patients enrolled in the multicenter OxyTC trial (NCT02754063).

Identifiants

pubmed: 35281992
doi: 10.3389/fneur.2021.740603
pmc: PMC8905597
doi:

Banques de données

ClinicalTrials.gov
['NCT02754063']

Types de publication

Journal Article

Langues

eng

Pagination

740603

Informations de copyright

Copyright © 2022 Mistral, Roca, Maggia, Tucholka, Forbes, Doyle, Krainik, Galanaud, Schmitt, Kremer, Kastler, Troprès, Barbier, Payen and Dojat.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

IEEE Trans Med Imaging. 2004 Jul;23(7):903-21
pubmed: 15250643
Anesthesiology. 2012 Dec;117(6):1300-10
pubmed: 23135261
PLoS One. 2013 Sep 03;8(9):e73021
pubmed: 24019889
Eur Radiol. 2006 Jul;16(7):1501-8
pubmed: 16485132
Med Image Anal. 2017 Feb;36:61-78
pubmed: 27865153
Lancet Neurol. 2008 Aug;7(8):728-41
pubmed: 18635021
Neuroimage. 2009 Jan 1;44(1):1-8
pubmed: 18804539
NMR Biomed. 2010 Aug;23(7):803-20
pubmed: 20886566
Med Image Anal. 2017 Feb;36:216-228
pubmed: 28011374
Med Image Anal. 2015 Apr;21(1):40-58
pubmed: 25596765
J Neurotrauma. 2019 Jun;36(11):1794-1803
pubmed: 30648469
Neuroimage Clin. 2014 Jul 24;7:87-97
pubmed: 25610770
AJNR Am J Neuroradiol. 2017 Aug;38(8):1501-1509
pubmed: 28642263
BMJ. 2000 Jun 17;320(7250):1631-5
pubmed: 10856063
Radiology. 2014 Jul;272(1):217-23
pubmed: 24635677
Magn Reson Imaging. 2012 May;30(4):496-505
pubmed: 22285880
J Neurotrauma. 2010 Feb;27(2):325-30
pubmed: 19895192
Brain Imaging Behav. 2012 Jun;6(2):137-92
pubmed: 22438191
Neuropharmacology. 2019 Feb;145(Pt B):230-246
pubmed: 30086289

Auteurs

Thomas Mistral (T)

Univ. Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France.

Pauline Roca (P)

Pixyl, Grenoble, France.

Christophe Maggia (C)

Univ. Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France.

Alan Tucholka (A)

Pixyl, Grenoble, France.

Florence Forbes (F)

Univ. Grenoble Alpes, Inria, CNRS, Grenoble INP, LJK, Grenoble, France.

Senan Doyle (S)

Pixyl, Grenoble, France.

Alexandre Krainik (A)

Univ. Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France.
Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, CNRS, IRMaGe, Grenoble, France.

Damien Galanaud (D)

APHP, Hôpital Pitié Salpétrière, Paris, France.

Emmanuelle Schmitt (E)

CHU, Hôpital Central, Nancy, France.

Stéphane Kremer (S)

CHU, de Strasbourg, Strasbourg, France.

Adrian Kastler (A)

Univ. Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France.

Irène Troprès (I)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, CNRS, IRMaGe, Grenoble, France.

Emmanuel L Barbier (EL)

Univ. Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France.
Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, CNRS, IRMaGe, Grenoble, France.

Jean-François Payen (JF)

Univ. Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France.

Michel Dojat (M)

Univ. Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France.

Classifications MeSH